#AI Drug Discovery

Architectural Interactivity, Linguistic Interpretability, and Molecular Synthesis: The Frontier of Native AI

Three organisations now define the frontier of native AI: Thinking Machines is rebuilding human-AI collaboration as a low-latency interaction model, the Effable movement wants interpretable safety frameworks like SafetyAnalyst, and Isomorphic Labs is converting AlphaFold into an end-to-end drug design engine. The common thread is moving from AI as a layer of abstraction toward AI as a fundamental component of human and biological systems.

AbbVie's AI Strategy: Reshaping Pharma from Discovery to Patient Impact

CNBC Disruptor 50 on Formation Bio to Redefine Drug Development

Kiin Bio Secures €1.9 Million Pre-Seed Funding for AI-Powered Drug Discovery Platform

London-based life sciences startup Kiin Bio has successfully raised €1.9 million in an oversubscribed pre-Seed funding round.

Kiin Bio Secures €1.9 Million Pre-Seed Funding for AI-Powered Drug Discovery Platform

London-based life sciences startup Kiin Bio has successfully raised €1.9 million in an oversubscribed pre-Seed funding round.

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI